normal human immunoglobulin

Spain

Drugs containing this active substance

  • FLEBOGAMMA DIF 100 MG/ML SOLUTION FOR INFUSION

    It is used to treat adults, children, and adolescents with antibody deficiencies (such as in Primary or Secondary Immunodeficiency Syndrome) or to prevent measles in individuals who cannot be vaccinated. It is also used to treat certain autoimmune conditions such as primary immune thrombocytopenia, Guillain-Barré Syndrome, Kawasaki disease, chronic inflammatory demyelinating polyradiculoneuropathy, and multifocal motor neuropathy.

    Form: solution for infusion

    Active substance Dosage
    normal human immunoglobulin 100 mg

    ATC: J06B J06BA J06BA02

    Manufacturer: Instituto Grifols S.A.

  • It is used to treat adults, children, and adolescents with antibody deficiencies (such as in Primary or Secondary Immunodeficiency Syndrome) and to prevent measles in individuals who cannot be vaccinated. It is also used to treat certain autoimmune conditions such as immune thrombocytopenia, Guillain-Barré Syndrome, Kawasaki disease, chronic inflammatory demyelinating polyradiculoneuropathy, and multifocal motor neuropathy.

    Form: solution for infusion

    Active substance Dosage
    normal human immunoglobulin 100 mg

    ATC: J06B J06BA J06BA02

    Manufacturer: Instituto Grifols S.A.

  • It is used to treat adults, children, and adolescents who have a lack of antibodies (such as in Primary or Secondary Immunodeficiency Syndrome) or to prevent measles in people who cannot be vaccinated. It is also used to treat certain autoimmune diseases such as primary immune thrombocytopenia, Guillain-Barré Syndrome, Kawasaki disease, chronic inflammatory demyelinating polyradiculoneuropathy, and multifocal motor neuropathy.

    Form: solution for infusion

    Active substance Dosage
    normal human immunoglobulin 100 mg

    ATC: J06B J06BA J06BA02

    Manufacturer: Instituto Grifols S.A.

  • It is used to treat adults, children, and adolescents who have insufficient levels of antibodies (such as in Primary or Secondary Immunodeficiency Syndrome) and to treat certain autoimmune conditions such as Immune Thrombocytopenia, Guillain-Barré Syndrome, Kawasaki Disease, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, and Multifocal Motor Neuropathy. It is also used to prevent measles in susceptible individuals.

    Form: solution for infusion

    Active substance Dosage
    normal human immunoglobulin 50 mg

    ATC: J06B J06BA J06BA02

    Manufacturer: Instituto Grifols S.A.

  • It is used to treat adults, children, and adolescents who do not have enough antibodies due to congenital or secondary deficiencies. It is also used to prevent measles in susceptible individuals and to treat certain autoimmune diseases such as primary immune thrombocytopenia, Guillain-Barré syndrome, Kawasaki disease, chronic inflammatory demyelinating polyradiculoneuropathy, and multifocal motor neuropathy.

    Form: solution for infusion

    Active substance Dosage
    normal human immunoglobulin 50 mg

    ATC: J06B J06BA J06BA02

    Manufacturer: Instituto Grifols S.A.

  • It is used to treat adults, children, and adolescents who have insufficient antibody levels (such as in Primary or Secondary Immunodeficiency Syndrome) or to prevent measles in people who cannot be vaccinated. It is also used to treat certain autoimmune conditions such as immune thrombocytopenia, Guillain-Barré Syndrome, Kawasaki disease, chronic inflammatory demyelinating polyradiculoneuropathy, and multifocal motor neuropathy.

    Form: solution for infusion

    Active substance Dosage
    normal human immunoglobulin 50 mg

    ATC: J06B J06BA J06BA02

    Manufacturer: Instituto Grifols S.A.

  • It is used to treat adults, children, and adolescents who have insufficient levels of antibodies due to congenital or secondary deficiencies. It is also used to prevent measles in susceptible individuals and to treat certain autoimmune diseases such as primary immune thrombocytopenia, Guillain-Barré syndrome, Kawasaki disease, chronic inflammatory demyelinating polyradiculoneuropathy, and multifocal motor neuropathy.

    Form: solution for infusion

    Active substance Dosage
    normal human immunoglobulin 50 mg

    ATC: J06B J06BA J06BA02

    Manufacturer: Instituto Grifols S.A.

  • It is used to treat adults, children, and adolescents who do not have enough antibodies due to immunity deficiencies (primary or secondary). It is also used to prevent measles in susceptible individuals and to treat certain autoimmune diseases, such as primary immune thrombocytopenia, Guillain-Barré syndrome, Kawasaki disease, chronic inflammatory demyelinating polyradiculoneuropathy, and multifocal motor neuropathy.

    Form: solution for infusion

    Active substance Dosage
    normal human immunoglobulin 50 mg

    ATC: J06B J06BA J06BA02

    Manufacturer: Instituto Grifols S.A.

  • It is used to treat people who do not have enough antibodies in their blood (such as in cases of immunodeficiencies, certain blood cancers, or transplants) and also to treat some inflammatory disorders such as Kawasaki disease, Guillain-Barré syndrome, or idiopathic thrombocytopenic purpura.

    Form: powder and solvent for solution for infusion

    Active substance Dosage
    normal human immunoglobulin 10 g

    ATC: J06B J06BA J06BA02

    Manufacturer: Baxalta Innovations Gmbh

  • It is used to treat patients who do not have enough antibodies in their blood (such as in cases of immunodeficiencies, certain blood cancers, or transplants) and to treat some inflammatory disorders such as Kawasaki disease, Guillain-Barré syndrome, or idiopathic thrombocytopenic purpura.

    Form: powder and solvent for solution for infusion

    Active substance Dosage
    normal human immunoglobulin 5000 mg

    ATC: J06B J06BA J06BA02

    Manufacturer: Baxalta Innovations Gmbh

  • It is used to treat adults, children, and adolescents who do not have enough antibodies (such as in primary immunodeficiency syndrome or acquired immunodeficiency), to prevent measles in people at risk of exposure, and to treat certain autoimmune diseases such as primary immune thrombocytopenia, Guillain-Barré syndrome, Kawasaki disease, chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, and severe myasthenia gravis crises.

    Form: solution for infusion

    Active substance Dosage
    normal human immunoglobulin 100 mg

    ATC: J06B J06BA J06BA02

    Manufacturer: Grifols Deutschland Gmbh

  • It is used to raise immunoglobulin levels in the blood in adults and children with immunodeficiencies (primary or secondary) and also to treat chronic inflammatory demyelinating polyneuropathy (CIDP), an autoimmune disease that affects the nerves.

    Form: solution for injection

    Active substance Dosage
    normal human immunoglobulin 200 mg/ml

    ATC: J06B J06BA J06BA01

    Manufacturer: Csl Behring Gmbh

  • It is used to raise immunoglobulin levels in the blood when they are abnormally low. It is prescribed in both adults and children to treat primary or secondary immunodeficiencies, and also to treat chronic inflammatory demyelinating polyneuropathy (CIDP).

    Form: solution for injection

    Active substance Dosage
    normal human immunoglobulin 200 mg

    ATC: J06B J06BA J06BA01

    Manufacturer: Csl Behring Gmbh

  • It is used to raise immunoglobulin levels in the blood in adults and children with immunodeficiencies (primary or secondary) and also to treat chronic inflammatory demyelinating polyneuropathy (CIDP), an autoimmune disease that affects the nerves.

    Form: solution for injection

    Active substance Dosage
    normal human immunoglobulin 200 mg

    ATC: J06B J06BA J06BA01

    Manufacturer: Csl Behring Gmbh

  • It is used to raise immunoglobulin levels in the blood in adults and children who have low levels due to genetic or acquired conditions. It is also used to treat chronic inflammatory demyelinating polyneuropathy (CIDP), an autoimmune disease that affects the nerves.

    Form: solution for injection

    Active substance Dosage
    normal human immunoglobulin 200 mg

    ATC: J06B J06BA J06BA01

    Manufacturer: Csl Behring Gmbh

  • It is used for patients with a weak immune system who do not have enough antibodies in the blood (primary or secondary immunodeficiencies) and for adults, children, and adolescents with chronic inflammatory demyelinating polyneuropathy (CIDP), an autoimmune disease that affects the nerves.

    Form: solution for infusion

    Active substance Dosage
    normal human immunoglobulin 100 mg

    ATC: J06B J06BA J06BA01

    Manufacturer: Baxalta Innovations Gmbh

  • It is used to treat patients with a weak immune system who do not have enough antibodies in the blood (primary or secondary immunodeficiencies) and for patients with chronic inflammatory demyelinating polyneuropathy (CIDP), an autoimmune disease that affects the nerves.

    Form: solution for infusion

    Active substance Dosage
    normal human immunoglobulin 100 mg

    ATC: J06B J06BA J06BA01

    Manufacturer: Baxalta Innovations Gmbh

  • Form: solution for infusion

    Active substance Dosage
    normal human immunoglobulin 100 mg

    ATC: J06B J06BA J06BA01

    Manufacturer: Baxalta Innovations Gmbh

  • It is used to treat patients with a weak immune system who do not have enough antibodies in the blood (primary or secondary immunodeficiencies) and for patients with chronic inflammatory demyelinating polyneuropathy (CIDP), an autoimmune disease that affects the nerves.

    Form: solution for infusion

    Active substance Dosage
    normal human immunoglobulin 100 mg

    ATC: J06B J06BA J06BA01

    Manufacturer: Baxalta Innovations Gmbh

  • It is used in adults and children with a weak immune system who do not have enough antibodies to fight infections. It is also used in adults, children, and adolescents with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), an autoimmune disease that affects the nerves.

    Form: solution for infusion

    Active substance Dosage
    normal human immunoglobulin 100 mg

    ATC: J06B J06BA J06BA01

    Manufacturer: Baxalta Innovations Gmbh

  • It is used to treat adults, children, and adolescents who do not have enough antibodies (replacement therapy) due to congenital or acquired deficiencies. It is also used to treat certain inflammatory conditions such as Immune Thrombocytopenia, Guillain-Barré syndrome, Kawasaki disease, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), and Multifocal Motor Neuropathy (MMN).

    Form: solution for infusion

    Active substance Dosage
    normal human immunoglobulin 50 mg

    ATC: J06B J06BA J06BA02

    Manufacturer: Kedrion S.P.A.

  • It is used to treat people (adults, children, and adolescents) who do not have enough antibodies to defend themselves against diseases, whether due to a congenital deficiency or an acquired one. It is also used to treat various inflammatory diseases such as Guillain-Barré syndrome, Kawasaki disease, or primary immune thrombocytopenia.

    Form: solution for infusion

    Active substance Dosage
    normal human immunoglobulin 100 mg

    ATC: J06B J06BA J06BA02

    Manufacturer: Biotest Pharma Gmbh

  • It is used to treat people who do not have enough antibodies (either from birth or because they have acquired a deficiency due to serious infections) and to treat various inflammatory diseases such as Guillain-Barré syndrome, Kawasaki disease, primary immune thrombocytopenia, and certain nerve diseases.

    Form: solution for infusion

    Active substance Dosage
    normal human immunoglobulin 50 mg

    ATC: J06B J06BA J06BA02

    Manufacturer: Biotest Pharma Gmbh

  • It is used to treat patients who do not have enough antibodies in their blood to fight infections and also to treat certain inflammatory disorders, such as Guillain-Barré Syndrome, Kawasaki disease, or primary immune thrombocytopenia.

    Form: solution for infusion

    Active substance Dosage
    normal human immunoglobulin 100 mg

    ATC: J06B J06BA J06BA02

    Manufacturer: Takeda Manufacturing Austria Ag

  • It is used to treat patients who do not have enough antibodies in their blood to fight infections and also to treat certain inflammatory disorders, such as Kawasaki disease, Guillain-Barré Syndrome, primary immune thrombocytopenia, and other nerve or organ diseases.

    Form: solution for infusion

    Active substance Dosage
    normal human immunoglobulin 100 mg

    ATC: J06B J06BA J06BA02

    Manufacturer: Takeda Manufacturing Austria Ag

  • It is used to treat patients who do not have enough antibodies in the blood to fight infections and to treat certain inflammatory disorders, such as Guillain-Barré Syndrome, Kawasaki disease, primary immune thrombocytopenia, and other neurological diseases.

    Form: solution for infusion

    Active substance Dosage
    normal human immunoglobulin 100 mg

    ATC: J06B J06BA J06BA02

    Manufacturer: Takeda Manufacturing Austria Ag

  • It is used to treat patients who do not have enough antibodies in their blood to fight infections and also to treat certain inflammatory disorders, such as Guillain-Barré Syndrome, Kawasaki disease, primary immune thrombocytopenia, and other nerve or organ diseases.

    Form: solution for infusion

    Active substance Dosage
    normal human immunoglobulin 100 mg

    ATC: J06B J06BA J06BA02

    Manufacturer: Takeda Manufacturing Austria Ag

  • It is used to treat people with antibody deficiency (whether congenital or acquired due to diseases or treatments), to protect children and adolescents exposed to measles when they cannot be vaccinated, and to treat certain autoimmune diseases such as Kawasaki disease, Guillain-Barré syndrome, or immune thrombocytopenia.

    Form: solution for infusion

    Active substance Dosage
    normal human immunoglobulin 100 mg

    ATC: J06B J06BA J06BA02

    Manufacturer: Octapharma S.A.

  • It is used as replacement therapy in children, adolescents, and adults with antibody deficiency (either inherited or acquired due to diseases or treatments). It is also used to protect vulnerable individuals exposed to measles and to treat certain autoimmune disorders such as Kawasaki disease, Guillain-Barré syndrome, immune thrombocytopenia (ITP), and other nervous system conditions.

    Form: solution for infusion

    Active substance Dosage
    normal human immunoglobulin 50 mg

    ATC: J06B J06BA J06BA02

    Manufacturer: Octapharma S.A.

  • It is used as replacement therapy for individuals with antibody deficiency (whether congenital or secondary) and to protect vulnerable children and adolescents exposed to measles. It is also used to treat certain autoimmune disorders such as immune thrombocytopenia (ITP), Kawasaki disease, Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP), and multifocal motor neuropathy (MMN).

    Form: solution for infusion

    Active substance Dosage
    normal human immunoglobulin 100 mg

    ATC: J06B J06BA J06BA02

    Manufacturer: Octapharma S.A.

  • It is used to treat adults and children with low levels of immunoglobulin in the blood (due to primary or acquired immunodeficiencies) and to treat various inflammatory disorders, such as immune thrombocytopenic purpura, Guillain-Barré syndrome, Kawasaki disease, chronic inflammatory demyelinating polyneuropathy, and multifocal motor neuropathy.

    Form: solution for infusion

    Active substance Dosage
    normal human immunoglobulin 100 mg

    ATC: J06B J06BA J06BA02

    Manufacturer: Csl Behring Gmbh

  • It is used to treat adults and children with low levels of immunoglobulin in the blood (due to primary or acquired immunodeficiencies) and to treat certain inflammatory disorders such as Immune Thrombocytopenic Purpura, Guillain-Barré syndrome, Kawasaki disease, chronic inflammatory demyelinating polyneuropathy, and multifocal motor neuropathy.

    Form: solution for infusion

    Active substance Dosage
    normal human immunoglobulin 100 mg

    ATC: J06B J06BA J06BA02

    Manufacturer: Csl Behring Gmbh

  • It is used to treat adults and children with low levels of immunoglobulin in the blood (due to primary or acquired immunodeficiencies) and to treat certain inflammatory disorders such as Immune Thrombocytopenic Purpura, Guillain-Barré syndrome, Kawasaki disease, chronic inflammatory demyelinating polyneuropathy, and multifocal motor neuropathy.

    Form: solution for infusion

    Active substance Dosage
    normal human immunoglobulin 100 mg

    ATC: J06B J06BA J06BA02

    Manufacturer: Csl Behring Gmbh

  • It is used to treat adults and children with low levels of immunoglobulin in the blood (due to primary or acquired immunodeficiencies) and to treat certain inflammatory disorders such as Immune Thrombocytopenic Purpura, Guillain-Barré syndrome, Kawasaki disease, chronic inflammatory demyelinating polyneuropathy, and multifocal motor neuropathy.

    Form: solution for infusion

    Active substance Dosage
    normal human immunoglobulin 100 mg

    ATC: J06B J06BA J06BA02

    Manufacturer: Csl Behring Gmbh

  • It is used to treat adults and children with low levels of immunoglobulin in the blood (due to primary or acquired immunodeficiencies) and to treat certain inflammatory disorders such as immune thrombocytopenic purpura, Guillain-Barré syndrome, Kawasaki disease, chronic inflammatory demyelinating polyneuropathy, and multifocal motor neuropathy.

    Form: solution for infusion

    Active substance Dosage
    normal human immunoglobulin 100 mg

    ATC: J06B J06BA J06BA02

    Manufacturer: Csl Behring Gmbh

  • It is used to treat adults, children, and adolescents who have very low levels of antibodies (immunoglobulins) due to conditions such as primary immunodeficiency syndrome, hypogammaglobulinemia related to chronic lymphocytic leukemia or multiple myeloma, and following a stem cell transplant.

    Form: solution for injection

    Active substance Dosage
    normal human immunoglobulin 18-22 PORCENTAJE

    ATC: J06B J06BA J06BA01

    Manufacturer: Instituto Grifols S.A.